NO20064315L - T1 MRI-sporbare medikamentavleveringspartikler and anvendelse derav - Google Patents

T1 MRI-sporbare medikamentavleveringspartikler and anvendelse derav

Info

Publication number
NO20064315L
NO20064315L NO20064315A NO20064315A NO20064315L NO 20064315 L NO20064315 L NO 20064315L NO 20064315 A NO20064315 A NO 20064315A NO 20064315 A NO20064315 A NO 20064315A NO 20064315 L NO20064315 L NO 20064315L
Authority
NO
Norway
Prior art keywords
drug delivery
traceable
mri
delivery particles
drug
Prior art date
Application number
NO20064315A
Other languages
English (en)
Inventor
Esben A Nilssen
Sigrid Fossheim
Original Assignee
Epitarget As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epitarget As filed Critical Epitarget As
Priority to NO20064315A priority Critical patent/NO20064315L/no
Priority to PCT/NO2007/000334 priority patent/WO2008035985A2/en
Priority to EP07808630A priority patent/EP2066357A2/en
Priority to US12/441,116 priority patent/US20100158817A1/en
Publication of NO20064315L publication Critical patent/NO20064315L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1812—Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)

Abstract

Den foreliggende oppfinnelsen beskriver et legemiddelavleveringssystem som tillater overvåking av romlig posisjon og legemiddelfrigjøring, så vel som fremgangsmåter og anvendelser derav. Mer spesielt omfatter legemiddelavleveringssystemet legemiddelbærende partikler omfattende en intern og ekstern distribusjon av magnetisk resonans avbildings kontrastmidler.
NO20064315A 2006-09-22 2006-09-22 T1 MRI-sporbare medikamentavleveringspartikler and anvendelse derav NO20064315L (no)

Priority Applications (4)

Application Number Priority Date Filing Date Title
NO20064315A NO20064315L (no) 2006-09-22 2006-09-22 T1 MRI-sporbare medikamentavleveringspartikler and anvendelse derav
PCT/NO2007/000334 WO2008035985A2 (en) 2006-09-22 2007-09-21 T1 mri trackable drug delivery particles, uses and methods thereof
EP07808630A EP2066357A2 (en) 2006-09-22 2007-09-21 T1 mri trackable drug delivery particles, uses and methods thereof
US12/441,116 US20100158817A1 (en) 2006-09-22 2007-09-21 T1 mri trackable drug delivery particles, uses and methods thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20064315A NO20064315L (no) 2006-09-22 2006-09-22 T1 MRI-sporbare medikamentavleveringspartikler and anvendelse derav

Publications (1)

Publication Number Publication Date
NO20064315L true NO20064315L (no) 2008-03-24

Family

ID=38805697

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064315A NO20064315L (no) 2006-09-22 2006-09-22 T1 MRI-sporbare medikamentavleveringspartikler and anvendelse derav

Country Status (4)

Country Link
US (1) US20100158817A1 (no)
EP (1) EP2066357A2 (no)
NO (1) NO20064315L (no)
WO (1) WO2008035985A2 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2142167A2 (en) * 2007-03-30 2010-01-13 Epitarget As Acoustically sensitive drug delivery particles
US12097269B2 (en) * 2010-10-27 2024-09-24 Vikas Kundra Dual mode gadolinium nanoparticle contrast agents
WO2012104275A2 (en) 2011-01-31 2012-08-09 Nanobiotix Nanoparticles delivery systems, preparation and uses thereof
EP2670393B8 (en) * 2011-01-31 2016-10-05 Nanobiotix Method of monitoring the release from liposomes of a product of interest using superparamagnetic nanoparticles.
EA029635B1 (ru) 2011-12-16 2018-04-30 Нанобиотикс Применение наночастицы, включающей металлический материал, покрытый материалом оксида гафния, в онкологии и композиция, ее содержащая
US20150202153A1 (en) * 2012-10-04 2015-07-23 University Of The Witwatersrand, Johannesburg Liposomal drug delivery system
KR20150078952A (ko) * 2013-12-31 2015-07-08 삼성전자주식회사 활성 성분 및 조영제를 포함하는 리포좀 및 그의 용도
UA124572C2 (uk) 2015-05-28 2021-10-13 Нанобіотікс Наночастинки для застосування як терапевтичної вакцини

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6132764A (en) * 1994-08-05 2000-10-17 Targesome, Inc. Targeted polymerized liposome diagnostic and treatment agents
US7672704B2 (en) 2002-09-11 2010-03-02 Duke University Methods and compositions for blood pool identification, drug distribution quantification and drug release verification
US20050112065A1 (en) * 2003-07-09 2005-05-26 Drummond Daryl C. Remote detection of substance delivery to cells
JP2007511616A (ja) * 2003-11-19 2007-05-10 バーンズ−ジューイッシュ ホスピタル 増強された薬物送達
US20050261170A1 (en) * 2004-01-22 2005-11-24 Immunomedics, Inc. Folate conjugates and complexes
EP1600153A1 (en) * 2004-05-26 2005-11-30 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Slow-release pharmaceutical composition allowing to monitor drug release
US20070292354A1 (en) 2004-09-23 2007-12-20 Guerbet Contrast Agents Encapsulating Systems for Cest Imaging
WO2007127231A2 (en) * 2006-04-24 2007-11-08 The Johns Hopkins University Magnetic resonance-detectable, ultrasound-detectable and/or radiopaque microcapsules and uses thereof

Also Published As

Publication number Publication date
EP2066357A2 (en) 2009-06-10
WO2008035985A2 (en) 2008-03-27
US20100158817A1 (en) 2010-06-24
WO2008035985A3 (en) 2008-07-31

Similar Documents

Publication Publication Date Title
NL1034839A1 (nl) Magnetische-resonantieafbeeldingsapparatuur.
NL2000185A1 (nl) Transporteerbaar magnetisch-resonantie-beeldvormings (MRI)-systeem.
EP1865882A4 (en) DEGRADABLE IMPLANTABLE MEDICINE PRODUCTS
MY158019A (en) Controlled activation ingestible identifier
EP1885415A4 (en) ADMINISTRATOR OF DOSAGE DOSES
NL1034804A1 (nl) Magnetische-resonantieafbeeldingsapparatuur en magnetische-resonantiefafbeeldingswerkwijze.
WO2010057082A3 (en) Diagnostic capsules, delivery/retrieval systems, kits and methods
DE602005016148D1 (de) Targetingmittel für molekulare bilderzeugung
EP2024871A4 (en) SYSTEMS AND METHODS FOR MANAGING THE DEVELOPMENT AND MANUFACTURE OF A MEDICAMENT
BRPI0716196A2 (pt) Sistemas de distribuição de fármacos que compreendem soluções sólidas de fármacos fracamente básicos.
IS2779B (is) Tafla með breyttan losunarhraða á búprópíónhýdróklóríði
HRP20160866T1 (hr) Postupci primjene hipoglikemijskih sredstava
WO2008033031A3 (en) Mri trackable drug delivery particles, uses and methods thereof
WO2008035985A3 (en) T1 mri trackable drug delivery particles, uses and methods thereof
UY30460A1 (es) Compuestos terapéuticos
NL1032695A1 (nl) Magnetische-resonantiebeeldvormingsapparatuur en -werkwijze.
NL1033060A1 (nl) Magnetische-resonantiebeeldvormingsapparatuur en -werkwijze.
EA201001857A1 (ru) Фармацевтическая лекарственная форма для немедленного высвобождения производного индолинона
BRPI0818607A2 (pt) Métodos para disseminar informação e para comunica informação relativa a atributos físicos de pacientes.
MY163383A (en) Degradable removable implant for the sustained release of an active compound
ES2604778T3 (es) Gránulos de oseltamivir fosfato y método de preparación de los mismos
PT2155255E (pt) Composições que incluem um composto hidrofóbico e um conjugado de poliaminoácido
EP2127677A4 (en) AMINO ALKYL METHACRYLATE COPOLYMER FOR MAINTAINING THE SOLUBILITY OF A HEAVY WATER-SOLUBLE MEDICAMENT
GB0613183D0 (en) Delivery of contrasting agents for magnetic resonance imaging
Bottenberg et al. Metronidazole-induced encephalopathy: a case report and review of the literature

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application